Back to search
FDAFDA · Food and drugs·Recall number D-0104-2025

Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 42291-902-28

Published December 11, 2024 · Recall initiated: October 18, 2024

Summary

FDA records drug Class II recall D-0104-2025, published December 11, 2024 and initiated October 18, 2024. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 20 bottles; Lot: Lot #: 100049501, Exp. Date 07/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix-Up

What to do

Voluntary: Firm initiated · Letter

Get an email if SUNITINIB MALATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SUNITINIB MALATE
Manufacturer
AvKARE
Distributor
Nationwide within the United States
Lot
Lot #: 100049501, Exp. Date 07/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 42291-902-28 recalled?

Yes. FDA published recall D-0104-2025 on December 11, 2024. Reported hazard: Labeling: Label Mix-Up

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SUNITINIB MALATE.